Palo Alto Investors

Palo Alto Investors as of Dec. 31, 2017

Portfolio Holdings for Palo Alto Investors

Palo Alto Investors holds 37 positions in its portfolio as reported in the December 2017 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Abiomed 12.8 $297M 1.6M 187.41
United Therapeutics Corporation (UTHR) 10.2 $238M 1.6M 147.95
Clovis Oncology 10.0 $231M 3.4M 68.00
BioMarin Pharmaceutical (BMRN) 9.6 $223M 2.5M 89.17
Insmed (INSM) 8.6 $200M 6.4M 31.18
Alexion Pharmaceuticals 5.8 $134M 1.1M 119.59
Sage Therapeutics (SAGE) 5.8 $134M 811k 164.71
Amicus Therapeutics (FOLD) 3.7 $86M 6.0M 14.39
Epizyme 3.7 $86M 6.9M 12.55
Immunomedics 3.3 $77M 4.8M 16.16
Vanda Pharmaceuticals (VNDA) 2.7 $63M 4.2M 15.20
Wright Medical Group Nv 2.6 $61M 2.7M 22.20
STAAR Surgical Company (STAA) 2.3 $54M 3.5M 15.50
ACADIA Pharmaceuticals (ACAD) 2.1 $49M 1.6M 30.11
Align Technology (ALGN) 2.0 $47M 213k 222.19
AMAG Pharmaceuticals 2.0 $46M 3.5M 13.25
Aimmune Therapeutics 1.9 $43M 1.1M 37.82
Prothena (PRTA) 1.8 $41M 1.1M 37.49
Karyopharm Therapeutics (KPTI) 1.5 $34M 3.5M 9.60
Celgene Corporation 1.4 $32M 308k 104.36
Momenta Pharmaceuticals 1.1 $25M 1.8M 13.95
Shire 0.9 $21M 136k 155.12
Alder Biopharmaceuticals 0.9 $21M 1.8M 11.45
EXACT Sciences Corporation (EXAS) 0.7 $16M 311k 52.54
Rigel Pharmaceuticals 0.7 $15M 3.9M 3.88
Bioverativ Inc Com equity 0.6 $14M 264k 53.92
Gilead Sciences (GILD) 0.5 $13M 176k 71.64
Dicerna Pharmaceuticals 0.2 $4.5M 501k 9.03
Sunesis Pharmaceuticals Inc Ne 0.2 $4.3M 1.2M 3.69
Alimera Sciences 0.2 $4.0M 3.0M 1.33
Idera Pharmaceuticals 0.1 $1.3M 616k 2.11
Zogenix 0.1 $1.2M 30k 40.03
Cytokinetics (CYTK) 0.0 $1.0M 124k 8.15
Histogenics Corp Cmn 0.0 $621k 303k 2.05
Melinta Therapeutics 0.0 $801k 51k 15.80
Sophiris Bio 0.0 $561k 247k 2.27
Trevena 0.0 $546k 341k 1.60